|
Facebook
Twitter
Linkedin
|
Multiple Sclerosis With FONAR UPRIGHT MRI Leads to Noninvasive Treatment
| Company News - FONAR Corporation |

Diagnostic Breakthrough in Multiple Sclerosis With FONAR UPRIGHT MRI Leads to Noninvasive Treatment That Results in Symptoms of MS Patient Subsiding.
FONAR Corporation, The Inventor of MR Scanning(TM), reported the cessation of symptoms in a 41-year-old female patient with multiple sclerosis following noninvasive treatment. The treatment was based on a recent major diagnostic breakthrough about the cause of multiple sclerosis achieved with the advanced FONAR UPRIGHT(R) MRI.
Misaligned cervical vertebrae in the patient (specifically, the vertebrae in the neck known as C-1, C-2, and C3) were causing blockage of the flow of cerebrospinal fluid. The malrotations of these vertebrae were initially discovered and visualized by the FONAR UPRIGHT(R) MRI, which showed that the vertebrae were rotated 5-6 degrees from their normal alignment.
When the vertebrae were successfully realigned, the patient's symptoms subsided. The realignment was achieved by Dr. Scott Rosa, (Rock Hill, NY), using the noninvasive Atlas Orthogonal (AO) instrument, a device that can be used to tap the vertebrae back into normal alignment.
The patient is currently being maintained free of her MS symptoms, (vertigo and vomiting on recumbency) when recumbent, by weekly treatment with the AO instrument.
In the original study on which the diagnostic breakthrough was based, the Upright MRI further revealed that the cervical misalignments in the patient resulted in impairment of the flow of cerebrospinal fluid (CSF) on the posterior side of the spinal cord at the cervical joint between C-2 and C-3. When obstructed, the 500 cc of CSF generated daily within the ventricles of the brain cannot exit the ventricle and circulate normally down the spinal canal and return to the brain. The resulting buildup of CSF pressure gives rise to leakages of CSF fluid into the brain tissue surrounding the ventricles. The swelling in this MS patient (patient #8 of the recent study of CSF flows of 8 MS patients) was particularly pronounced in what are known as the posterior horns of the lateral ventricles. (Fig. 8, Damadian, R.V. and Chu, D., "The Possible Role of Cranio-Cervical Trauma and Abnormal CSF Hydrodynamics in the Genesis of Multiple Sclerosis" Physiol. Chem. and Physics and Medical NMR, September 20, 2011,41:1-17).
The CSF leakages visualized were connected directly to the MS lesions visible in the MRI scans (Fig. 8). It became apparent to researcher Dr. Raymond Damadian that these leakages might be the cause of the brain lesions of MS patients.
Following treatment of the patient's cervical malrotations, which was performed by Dr. Scott Rosa (Rock Hill, NY), Upright MRI scans, as well as X-rays obtained by Dr. Rosa, showed that the cervical malrotations had been restored to normal.
At the same time, the patient reported that her severe vertigo and vomiting in the recumbent (lying down) position had ceased and that her stumbling from unequal leg length had disappeared.
When her MS symptoms had ceased, velocity maps (Fig. 16a & 16b) of the CSF flow through the spinal canal in the cervical area showed a striking reduction in the average velocity of the CSF fluid through the cervical area of the spinal cord, when compared to the CSF velocities before treatment (Fig. 16a). The flows are exhibited in graphs that record the velocity of the fluid in the flow pixels of the velocity maps. Notice the marked reduction in the number of high velocity CSF flow jets (red) after treatment, as compared with the number present prior to treatment. The high speed jets are caused by blockage of the flow of the CSF fluid, which compensates for the obstructions with increased flow rates in the unobstructed regions.
The reduction in the average velocity of CSF jets in the spinal canal corresponded with the patient's report that her MS symptoms had ceased. Concurrent with the CSF velocity measurements (Figs. 16a and 16b), a quantitative determination of the patient's CSF flow revealed that a 28.6% reduction in the patient's CSF pressure accompanied the cessation of her MS symptoms.
Source: FONAR Corporation











